Qumata
5 New Street Square, London, EC4A 3TW, United Kingdom
Overview
Qumata offers a machine learning and artificial intelligence underwriting solution aimed at transforming underwriting for life and health insurers. The company uses digital data to calculate the risk of diagnosis for over 800 conditions, as well as Extra Mortalities and Morbidities, reducing the need for long questionnaires or doctor visits. Qumata positions its technology to retain underwriting accuracy while improving customer experience and enabling new revenue opportunities for insurers. The firm has offices in London, Hong Kong, Shanghai, Tokyo and Singapore and has been expanding its team and partnerships to support growth. Qumata recently signed an agreement with AIA Group to provide services across Asia and is focused on accelerating digital transformation in the life and health insurance industry. The company announced a Series A extension to support global expansion, with a particular focus on Asia and the U.K. HealthyHealth announced a $10 million funding round that closed on June 3, 2021. The round was led by new investor MMC Ventures Limited. The transaction included participation from AdirVentures, a number of family offices, and existing investor TMT Investments PLC (AIM:TMT). As part of the transaction, Oliver Richards of MMC Ventures Limited and Barry Karfunkel of AdirVentures joined HealthyHealth's board of directors. The announcement does not disclose the use of proceeds, valuation, or other operating metrics. No details on the company’s product, founding year, location, revenue, or user metrics were provided in the articles.
- Total raised
- $33M
- Funding rounds
- 2
- Latest round
- Series A
- Latest activity
- Feb 2022
Industries
- InsurTech
Recent funding
Series A
Feb 2022
$23M
Series A
Jun 2021
$10M